Is cefepime safe for clinical use? A Bayesian viewpoint

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1207-1209

  Kalil, Andre C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adverse events; Cephalosporin; Statistics

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; CEFEPIME; CEFTAZIDIME; IMIPENEM; MEROPENEM; PIPERACILLIN; QUINOLONE; TICARCILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC THERAPY; ARTICLE; BAYES THEOREM; DRUG FATALITY; DRUG SAFETY; DRUG USE; FEBRILE NEUTROPENIA; FOOD AND DRUG ADMINISTRATION; HUMAN; META ANALYSIS; META ANALYSIS (TOPIC); MORTALITY; PNEUMONIA; RISK ASSESSMENT; SKIN INFECTION; TREATMENT INDICATION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; FEVER OF UNKNOWN ORIGIN; HUMANS; INCIDENCE; NEUTROPENIA; SKIN DISEASES, BACTERIAL; STATISTICS AS TOPIC; UNITED STATES;

EID: 79956044508     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr138     Document Type: Article

References (9)

1. Elan Pharmaceuticals I. Maxipimew Drug Insert January 2007. http://elan.com/images/maxipime_pi_tcm3-4348.pdf (22 June 2009, date last accessed).
2. Yahav D, Paul M, Fraser A et al. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 338-48.
3. US Food and Drug Administration. Early Communication About an Ongoing Safety Review of Cefepime (Marketed as Maxipime) 06/18/2009. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm070496.htm (22 December 2010, date last accessed).
4. US Food and Drug Administration. Cefepime (Marketed as Maxipime). Update of Ongoing Safety Review 06/19/2009. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm167427.htm (22 December 2010, date last accessed).
5. US Food and Drug Administration Center for Drug Evaluation and Research. Statistical Review and Evaluation. Clinical Studies NDA Number 50-679. Drug Name: Maxipime 04/22/2009. http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/Drug%20SafetyInfomationforHealthcareProfessionals/UCM167309.htm (22 December 2010, date last accessed).
6. Kim PW, Wu YT, Cooper Cet al. eta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 2010; 51: 381-9.
7. Kalil AC, Sun J. Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis. PLoS ONE 2008; 3: e2291.
8. Leibovici L, Yahav D, Paul M. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 2010; 51: 1350-1; author reply 1351-2.
9. Klein DF, O'Brien CP. Improving detection of adverse effects of marketed drugs. JAMA 2007; 298: 333-4.